Back to search

University of Glasgow

The Control of Cyclosporin in Transplantation: Pharmacokinetic Aspects

Abstract

dc:description.abstract

Cyclosporin is a relatively new immunosuppressant drug which has been shown to be useful in prevention of graft rejection following organ transplantation. Its major disadvantage is its toxicity, which appears to be related to high concentrations of the drug. Low concentrations are associated with rejection episodes. The aim of cyclosporin dosing is to achieve cyclosporin concentrations which minimise both toxicity and rejection. Individualisation of therapy is necessary since cyclosporin has a narrow 'therapeutic range' and also exhibits wide pharmacokinetic variability. The aims of this work are to quantify the pharmacokinetic variability of cyclosporin in renal and liver transplant patients in an attempt to improve control of therapy.

Degree

thesis:*
Level dc:type.qualificationlevel
PhD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
1990

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Niven, Alison A

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Niven, Alison A. The Control of Cyclosporin in Transplantation: Pharmacokinetic Aspects. PhD thesis, University of Glasgow, 1990.